 | • レポートコード：QYR9ST03920 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、免疫療法薬の世界市場について調査・分析し、免疫療法薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（モノクローナル抗体、成人ワクチン、チェックポイント阻害剤、インターフェロンアルファおよびベータ、インターロイキン、その他）、用途別（癌、自己免疫疾患、炎症性疾患、感染症、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の免疫療法薬市場動向 ・主要企業別マーケットシェア ・免疫療法薬の種類別市場規模2014-2019 （モノクローナル抗体、成人ワクチン、チェックポイント阻害剤、インターフェロンアルファおよびベータ、インターロイキン、その他） ・免疫療法薬の用途別市場規模2014-2019 （癌、自己免疫疾患、炎症性疾患、感染症、その他） ・免疫療法薬の北米市場：主要企業・種類別/用途別市場規模 ・免疫療法薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・免疫療法薬の中国市場：主要企業・種類別/用途別市場規模 ・免疫療法薬の日本国内市場：主要企業・種類別/用途別市場規模 ・免疫療法薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・免疫療法薬のインド市場：主要企業・種類別/用途別市場規模 ・免疫療法薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Roche、Merck、Novartis、Johnson & Johnson、Glaxosmithkline、Amgen、Abbvie、Astrazeneca、Bristol-Myers Squibb、ELI Lilly） ・免疫療法薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.North America is expected to account for largest share in the immunotherapy drugs market, by region in 2018. Asia-Pacific is expected to be the fastest-growing regional segment in the market. The high growth of this segment can primarily be attributed to the low cost of manufacturing and acceptable regulatory scenario in this region.
In 2018, the global Immunotherapy Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Immunotherapy Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunotherapy Drugs development in United States, Europe and China.
The key players covered in this study
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly
Market segment by Type, the product can be split into
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Others
Market segment by Application, split into
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Immunotherapy Drugs status, future forecast, growth opportunity, key market and key players.
To present the Immunotherapy Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Immunotherapy Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immunotherapy Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibodies
1.4.3 Adult Vaccines
1.4.4 Checkpoint Inhibitors
1.4.5 Interferons Alpha & Beta
1.4.6 Interleukins
1.4.7 Others
1.5 Market by Application
1.5.1 Global Immunotherapy Drugs Market Share by Application (2014-2025)
1.5.2 Cancer
1.5.3 Autoimmune & Inflammatory Diseases
1.5.4 Infectious Diseases
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Immunotherapy Drugs Market Size
2.2 Immunotherapy Drugs Growth Trends by Regions
2.2.1 Immunotherapy Drugs Market Size by Regions (2014-2025)
2.2.2 Immunotherapy Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Immunotherapy Drugs Market Size by Manufacturers
3.1.1 Global Immunotherapy Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Immunotherapy Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Immunotherapy Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Immunotherapy Drugs Key Players Head office and Area Served
3.3 Key Players Immunotherapy Drugs Product/Solution/Service
3.4 Date of Enter into Immunotherapy Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Immunotherapy Drugs Market Size by Type (2014-2019)
4.2 Global Immunotherapy Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Immunotherapy Drugs Market Size (2014-2019)
5.2 Immunotherapy Drugs Key Players in United States
5.3 United States Immunotherapy Drugs Market Size by Type
5.4 United States Immunotherapy Drugs Market Size by Application
6 Europe
6.1 Europe Immunotherapy Drugs Market Size (2014-2019)
6.2 Immunotherapy Drugs Key Players in Europe
6.3 Europe Immunotherapy Drugs Market Size by Type
6.4 Europe Immunotherapy Drugs Market Size by Application
7 China
7.1 China Immunotherapy Drugs Market Size (2014-2019)
7.2 Immunotherapy Drugs Key Players in China
7.3 China Immunotherapy Drugs Market Size by Type
7.4 China Immunotherapy Drugs Market Size by Application
8 Japan
8.1 Japan Immunotherapy Drugs Market Size (2014-2019)
8.2 Immunotherapy Drugs Key Players in Japan
8.3 Japan Immunotherapy Drugs Market Size by Type
8.4 Japan Immunotherapy Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Immunotherapy Drugs Market Size (2014-2019)
9.2 Immunotherapy Drugs Key Players in Southeast Asia
9.3 Southeast Asia Immunotherapy Drugs Market Size by Type
9.4 Southeast Asia Immunotherapy Drugs Market Size by Application
10 India
10.1 India Immunotherapy Drugs Market Size (2014-2019)
10.2 Immunotherapy Drugs Key Players in India
10.3 India Immunotherapy Drugs Market Size by Type
10.4 India Immunotherapy Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Immunotherapy Drugs Market Size (2014-2019)
11.2 Immunotherapy Drugs Key Players in Central & South America
11.3 Central & South America Immunotherapy Drugs Market Size by Type
11.4 Central & South America Immunotherapy Drugs Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immunotherapy Drugs Introduction
12.1.4 Roche Revenue in Immunotherapy Drugs Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immunotherapy Drugs Introduction
12.2.4 Merck Revenue in Immunotherapy Drugs Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immunotherapy Drugs Introduction
12.3.4 Novartis Revenue in Immunotherapy Drugs Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immunotherapy Drugs Introduction
12.4.4 Johnson & Johnson Revenue in Immunotherapy Drugs Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Glaxosmithkline
12.5.1 Glaxosmithkline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immunotherapy Drugs Introduction
12.5.4 Glaxosmithkline Revenue in Immunotherapy Drugs Business (2014-2019)
12.5.5 Glaxosmithkline Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immunotherapy Drugs Introduction
12.6.4 Amgen Revenue in Immunotherapy Drugs Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Abbvie
12.7.1 Abbvie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Immunotherapy Drugs Introduction
12.7.4 Abbvie Revenue in Immunotherapy Drugs Business (2014-2019)
12.7.5 Abbvie Recent Development
12.8 Astrazeneca
12.8.1 Astrazeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Immunotherapy Drugs Introduction
12.8.4 Astrazeneca Revenue in Immunotherapy Drugs Business (2014-2019)
12.8.5 Astrazeneca Recent Development
12.9 Bristol-Myers Squibb
12.9.1 Bristol-Myers Squibb Company Details
12.9.2 Company Description and Business Overview
12.9.3 Immunotherapy Drugs Introduction
12.9.4 Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2014-2019)
12.9.5 Bristol-Myers Squibb Recent Development
12.10 ELI Lilly
12.10.1 ELI Lilly Company Details
12.10.2 Company Description and Business Overview
12.10.3 Immunotherapy Drugs Introduction
12.10.4 ELI Lilly Revenue in Immunotherapy Drugs Business (2014-2019)
12.10.5 ELI Lilly Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Immunotherapy Drugs Key Market Segments
Table Key Players Immunotherapy Drugs Covered
Table Global Immunotherapy Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Immunotherapy Drugs Market Size Market Share by Type 2014-2025
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Adult Vaccines Figures
Table Key Players of Adult Vaccines
Figure Checkpoint Inhibitors Figures
Table Key Players of Checkpoint Inhibitors
Figure Interferons Alpha & Beta Figures
Table Key Players of Interferons Alpha & Beta
Figure Interleukins Figures
Table Key Players of Interleukins
Figure Others Figures
Table Key Players of Others
Table Global Immunotherapy Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Cancer Case Studies
Figure Autoimmune & Inflammatory Diseases Case Studies
Figure Infectious Diseases Case Studies
Figure Others Case Studies
Figure Immunotherapy Drugs Report Years Considered
Table Global Immunotherapy Drugs Market Size 2014-2025 (Million US$)
Figure Global Immunotherapy Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Immunotherapy Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Immunotherapy Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Immunotherapy Drugs Market Share by Regions 2014-2019
Figure Global Immunotherapy Drugs Market Share by Regions 2014-2019
Figure Global Immunotherapy Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Immunotherapy Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Immunotherapy Drugs Market Share by Manufacturers (2014-2019)
Figure Global Immunotherapy Drugs Market Share by Manufacturers in 2018
Table Global Immunotherapy Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Immunotherapy Drugs Product/Solution/Service
Table Date of Enter into Immunotherapy Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Immunotherapy Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Immunotherapy Drugs Market Size Share by Type (2014-2019)
Figure Global Immunotherapy Drugs Market Size Market Share by Type (2014-2019)
Table Global Immunotherapy Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Immunotherapy Drugs Market Size Share by Application (2014-2019)
Figure Global Immunotherapy Drugs Market Size Market Share by Application (2014-2019)
Figure Global Immunotherapy Drugs Revenue Market Share by Application in 2018
Figure United States Immunotherapy Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Immunotherapy Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Immunotherapy Drugs Market Share (2018-2019)
Table United States Immunotherapy Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Immunotherapy Drugs Market Share by Type (2014-2019)
Table United States Immunotherapy Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Immunotherapy Drugs Market Share by Application (2014-2019)
Figure Europe Immunotherapy Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Immunotherapy Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Immunotherapy Drugs Market Share (2018-2019)
Table Europe Immunotherapy Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Immunotherapy Drugs Market Share by Type (2014-2019)
Table Europe Immunotherapy Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Immunotherapy Drugs Market Share by Application (2014-2019)
Figure China Immunotherapy Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Immunotherapy Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Immunotherapy Drugs Market Share (2018-2019)
Table China Immunotherapy Drugs Market Size by Type (2014-20189) (Million US$)
Table China Immunotherapy Drugs Market Share by Type (2014-2019)
Table China Immunotherapy Drugs Market Size by Application (2014-2019) (Million US$)
Table China Immunotherapy Drugs Market Share by Application (2014-2019)
Figure Japan Immunotherapy Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Immunotherapy Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Immunotherapy Drugs Market Share (2018-2019)
Table Japan Immunotherapy Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Immunotherapy Drugs Market Share by Type (2014-2019)
Table Japan Immunotherapy Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Immunotherapy Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Immunotherapy Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Immunotherapy Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Immunotherapy Drugs Market Share (2018-2019)
Table Southeast Asia Immunotherapy Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Immunotherapy Drugs Market Share by Type (2014-2019)
Table Southeast Asia Immunotherapy Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Immunotherapy Drugs Market Share by Application (2014-2019)
Figure India Immunotherapy Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Immunotherapy Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Immunotherapy Drugs Market Share (2018-2019)
Table India Immunotherapy Drugs Market Size by Type (2014-2019) (Million US$)
Table India Immunotherapy Drugs Market Share by Type (2014-2019)
Table India Immunotherapy Drugs Market Size by Application (2014-2019) (Million US$)
Table India Immunotherapy Drugs Market Share by Application (2014-2019)
Figure Central & South America Immunotherapy Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Immunotherapy Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Immunotherapy Drugs Market Share (2018-2019)
Table Central & South America Immunotherapy Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Immunotherapy Drugs Market Share by Type (2014-2019)
Table Central & South America Immunotherapy Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Immunotherapy Drugs Market Share by Application (2014-2019)
Table Roche Company Details
Table Roche Revenue in Immunotherapy Drugs Business (2014-2019) (Million US$)
Figure Roche Revenue Growth Rate in Immunotherapy Drugs Business (2014-2019)
Table Roche Recent Development
Table Merck Company Details
Table Merck Revenue in Immunotherapy Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Immunotherapy Drugs Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Immunotherapy Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Immunotherapy Drugs Business (2014-2019)
Table Novartis Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Immunotherapy Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Immunotherapy Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Glaxosmithkline Company Details
Table Glaxosmithkline Revenue in Immunotherapy Drugs Business (2014-2019)(Million US$)
Figure Glaxosmithkline Revenue Growth Rate in Immunotherapy Drugs Business (2014-2019)
Table Glaxosmithkline Recent Development
Table Amgen Company Details
Table Amgen Revenue in Immunotherapy Drugs Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Immunotherapy Drugs Business (2014-2019)
Table Amgen Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in Immunotherapy Drugs Business (2014-2019)(Million US$)
Figure Abbvie Revenue Growth Rate in Immunotherapy Drugs Business (2014-2019)
Table Abbvie Recent Development
Table Astrazeneca Company Details
Table Astrazeneca Revenue in Immunotherapy Drugs Business (2014-2019)(Million US$)
Figure Astrazeneca Revenue Growth Rate in Immunotherapy Drugs Business (2014-2019)
Table Astrazeneca Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Immunotherapy Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table ELI Lilly Company Details
Table ELI Lilly Revenue in Immunotherapy Drugs Business (2014-2019)(Million US$)
Figure ELI Lilly Revenue Growth Rate in Immunotherapy Drugs Business (2014-2019)
Table ELI Lilly Recent Development
Table Global Immunotherapy Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Immunotherapy Drugs Market Size Share by Regions (2019-2025)
Figure Global Immunotherapy Drugs Market Size Share by Regions in 2025
Figure United States Immunotherapy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Immunotherapy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Immunotherapy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Immunotherapy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Immunotherapy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Immunotherapy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Immunotherapy Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Immunotherapy Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Immunotherapy Drugs Market Size by Product (2019-2025)
Figure Global Immunotherapy Drugs Market Size by Product in 2025
Table Global Immunotherapy Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Immunotherapy Drugs Market Size by Application (2019-2025)
Figure Global Immunotherapy Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
腎臓癌治療薬の世界市場：市場規模・現状・予測 Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. In 2018, the gl…- 免疫療法の世界市場：インサイト・予測 Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy.The global Immunotherapy marke…
- 尿路上皮がん薬の世界市場：市場規模・現状・予測 Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounte…
- 尿路上皮がん薬の世界市場：市場規模・現状・予測 Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounte…
- 乳がんモノクローナル抗体の世界市場：市場規模・現状・予測 Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…